BRKR
NASDAQ · Life Sciences Tools & Services
Bruker Corp
$42.88
-1.28 (-2.90%)
Financial Highlights (FY 2026)
Revenue
3.47B
Net Income
-8,700,494
Gross Margin
47.1%
Profit Margin
-0.3%
Rev Growth
+10.7%
D/E Ratio
0.76
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 47.1% | 47.1% | 67.6% | 67.6% |
| Operating Margin | 1.4% | 1.3% | 13.4% | 14.0% |
| Profit Margin | -0.3% | -0.2% | 11.5% | 12.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 3.47B | 3.14B | 1.92B | 2.28B |
| Gross Profit | 1.64B | 1.48B | 1.30B | 1.54B |
| Operating Income | 48.63M | 39.52M | 256.32M | 318.62M |
| Net Income | -8,700,494 | -7,071,017 | 220.32M | 272.46M |
| Gross Margin | 47.1% | 47.1% | 67.6% | 67.6% |
| Operating Margin | 1.4% | 1.3% | 13.4% | 14.0% |
| Profit Margin | -0.3% | -0.2% | 11.5% | 12.0% |
| Rev Growth | +10.7% | +10.7% | +23.7% | -3.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.42B | 1.42B | 752.51M | 754.20M |
| Total Equity | 1.87B | 1.87B | 2.63B | 2.39B |
| D/E Ratio | 0.76 | 0.76 | 0.29 | 0.32 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 274.44M | 235.43M | 370.66M | 419.03M |
| Free Cash Flow | — | — | 246.46M | 325.34M |